Here are our top highlights from Day 1 of the Advanced Therapies London 2023:

👉 We need to improve access to clinical trials. Currently, only 20% of eligible patients actually receive CART therapies – Bruce Levine, University of Pennsylvania

👉 We need to maximise learning and understanding for clinical trials, including the small rare disease trials, across the whole value chain from clinical to manufacturing – Federico Mingozzi, Spark Therapeutics